The Role of Vitamin D in Alzheimer's Disease: Possible Genetic and Cell Signaling Mechanisms

被引:27
|
作者
Khanh Vinh Quoc Lu'o'ng [1 ]
Lan Thi Hoang Nguyen [1 ]
机构
[1] Vietnamese Amer Med Res Fdn, Westminster, CA 92683 USA
来源
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS | 2013年 / 28卷 / 02期
关键词
calcitriol; vitamin D; Alzheimer's disease; dementia; CALCIUM-SENSING RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; WORSE COGNITIVE PERFORMANCE; D-3 INHIBITS PROLIFERATION; TRANSGENIC MOUSE MODEL; GLYCATION END-PRODUCTS; AMYLOID-BETA-PEPTIDE; D DEFICIENCY; MATRIX METALLOPROTEINASES;
D O I
10.1177/1533317512473196
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) is the most common form of dementia in the elderly individuals and is associated with progressive memory loss and cognitive dysfunction. A significant association between AD and low levels of vitamin D has been demonstrated. Furthermore, vitamin D supplements appear to have a beneficial clinical effect on AD by regulating micro-RNA, enhancing toll-like receptors, modulating vascular endothelial factor expression, modulating angiogenin, and advanced glycation end products. Vitamin D also exerts its effects on AD by regulating calcium-sensing receptor expression, enhancing amyloid-beta peptides clearance, interleukin 10, downregulating matrix metalloproteinases, upregulating heme oxygenase 1, and suppressing the reduced form of nicotinamide adenine dinucleotide phosphate expression. In conclusion, vitamin D may play a beneficial role in AD. Calcitriol is the best vitamin D supplement for AD, because it is the active form of the vitamin D3 metabolite and modulates inflammatory cytokine expression. Therefore, further investigation of the role of calcitriol in AD is needed.
引用
收藏
页码:126 / 136
页数:11
相关论文
共 50 条
  • [31] VITAMIN D IN ALZHEIMER'S DISEASE - PROPHYLAXIS OR THERAPY?
    Gruber-Bzura, Beata M.
    ACTA POLONIAE PHARMACEUTICA, 2016, 73 (06): : 1427 - 1431
  • [32] Aluminium and Alzheimer's disease: Review of possible pathogenic mechanisms
    Armstrong, RA
    Winsper, SJ
    Blair, JA
    DEMENTIA, 1996, 7 (01): : 1 - 9
  • [33] The possible role of the immune system in Alzheimer's disease
    Marx, F
    Blasko, I
    Pavelka, M
    Grubeck-Loebenstein, B
    EXPERIMENTAL GERONTOLOGY, 1998, 33 (7-8) : 871 - 881
  • [34] Possible Mechanisms of Tau Spread and Toxicity in Alzheimer's Disease
    Zhang, Huiqin
    Cao, Yu
    Ma, Lina
    Wei, Yun
    Li, Hao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [35] Low use of analgesics in Alzheimer's disease: Possible mechanisms
    Scherder, EJA
    PSYCHIATRY-INTERPERSONAL AND BIOLOGICAL PROCESSES, 2000, 63 (01): : 1 - 12
  • [36] Apolipoprotein J in Alzheimer's Disease: Shedding Light on Its Role with Cell Signaling Pathway Perspective and Possible Therapeutic Approaches
    Moezzi, Seyed-Mohammad-Iman
    Mozafari, Negin
    Fazel-Hoseini, Seyed-Mostafa
    Nadimi-Parashkoohi, Sadra
    Abbasi, Hosein
    Ashrafi, Hajar
    Azadi, Amir
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (24): : 4060 - 4072
  • [37] A possible role for vitamin D receptor gene polymorphism in the aetiology of Crohn's disease?
    Simmons, JD
    Mullighan, C
    Welsh, KI
    Jewell, DP
    GUT, 1997, 41 : A176 - A176
  • [38] Possible neurophysiological markers of genetic predisposition to Alzheimer's disease
    Ponomareva, NV
    Fokin, VF
    Selesneva, ND
    Voskresenskaia, NI
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1998, 9 (05) : 267 - 273
  • [39] Role of RhoA/ROCK signaling in Alzheimer's disease
    Cai, RuoLan
    Wang, YangYang
    Huang, ZhenTing
    Zou, Qian
    Pu, YinShuang
    Yu, Changyin
    Cai, Zhiyou
    BEHAVIOURAL BRAIN RESEARCH, 2021, 414
  • [40] Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer's Disease
    Govindarajulu, Manoj
    Pinky, Priyanka D.
    Bloemer, Jenna
    Ghanei, Nila
    Suppiramaniam, Vishnu
    Amin, Rajesh
    PPAR RESEARCH, 2018, 2018